drugset / Trial / NCT03814148

Efficacy and Safety of Leningrado 5 Association in the Treatment of Hypertension

NCT03814148 ↗

Phase 3 Withdrawn EMS
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of Leningrado 5 association on the treatment of hypertension.

Timeline

Start
2019-06
Primary completion
2020-06
Completion
2020-09

Outcome

Outcome not reported

Stopped: “The design of this protocol was rewritten due to regulatory recommendations.”

Drugs

EvaluationDrugModalityDoseRoute
Subject LENINGRADO 5 association Unknown — Oral
Comparator Natrilix® SR Unknown 1.5 mg Oral

Indications